medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2012, Number 3

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2012; 28 (3)

A revival of intraosseous route for hematopoietic transplantation?

Dorticós-Balea E, Anoceto-Martínez A, Roque-García W, Sarduy-Sáez S, Jaime-Fagundo JC, Hernández-Ramírez P

Language: Spanish
References: 31
Page: 217-225
PDF size: 260.83 Kb.


ABSTRACT

The direct intraosseous access for hematopoietic cell transplantation was first used by Josefson in 1934, as a method to treat pernicious anemia. Later, the use of tintravenous access became normal, based on knowledge of hematopoietic cells migration to the bone marrow once injected into the systemic circulation. The transplantation of blood cells from the umbilical cord has developed significantly in recent years. Among its disadvantages is that, generally, the number of cells obtained are insufficient, especially for using in adult patients. Therefore, it is important to increase the number of cells injected and to reach the core. One way to do this is by placing them directly into the marrow space. Preclinical studies have shown the effectiveness of this approach. Clinical studies are scarce and with conflicting results, so it is necessary to continue developing this method which appears to be useful in certain situations.


REFERENCES

  1. Josefson A. A new method of treatment-intraossal injections. Acta Med Scand. 1934;81:550-64.

  2. Tocantins L, O'Neill J, Jones H. Infusions of blood and other fluids via the bone marrow: application in pediatrics. J Am Med Assoc. 1941;117(15):1229-34. doi:10.1001/jama.1941.02820410007002.

  3. Smith R, Davis N, Bouamra O, Lecky F. The utilisation of intraosseous infusion in the resuscitation of paediatric major trauma patients. Injury. 2005 Sep;36(9):1034-8.

  4. Migdalska KZ. Special section transplantation of bone marrow. Blood. 1958 March;13(3):266-301.

  5. Morrison M, Samwick AA. Intramedullary (sternal) trans- versus-host syndrome in man. A long-term clinicopathologic fusion of human bone marrow. J Am Med Assoc. 1940;115(20):1708-11. doi:10.1001/jama.1940.02810460040010 .

  6. Osgood EE, Riddle MC, Mathews TJ. Aplastic anemia treated with daily transfusions and intravenous bone marrow: case report. Ann Intern Med. 1939 Aug;13(2):357-67.

  7. Dorticós-Balea E, González-Otero A, Hernández-Ramírez P. El trasplante de médula ósea en Cuba. Aportes del Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter. [serie en Internet]. 1997;12(2). Disponible en: http://bvs.sld.cu/revistas/hih/vol12_2_96/hih08296.htm

  8. Thomas ED, Lochte HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med.1957 Sep 12;257(11):491-6.

  9. Sullivan KM, Parkman R, Walters MC. Bone marrow transplantation for non-malignant disease. Hematology Am Soc Hematol Educ Program. 2000:319-38.

  10. Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, et al. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;Sep;14(9 Suppl):8-15.

  11. Cui J, Wahl RL, Shen T, Fisher SJ, Recker E, Ginsburg D, et al. Bone marrow cell trafficking following intravenous administration. Br J Haematol. 1999 Dec;107(4):895-902.

  12. Jaime-Fagundo JC, Dorticós-Balea E, Pavón- Morán V, Cortina-Rosales L. Trasplante de células progenitoras hematopoyéticas: tipos, fuentes e indicaciones. Rev Cubana Hematol Inmunol Hemoter. [serie en Internet]. 2004 Ago [citado 2011 Dic 05] ; 20(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892004000200002&lng=es

  13. Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant. 2008 Jan;41(2):207-14.

  14. Shi-Xia X, Xian-Hua T, Xiang-Feng T. Unrelated umbilical cord blood transplantation and unrelated bone marrow transplantation in children with hematological disease: a meta-analysis. Pediatr Transplant. 2009 May;13(3):278-84.

  15. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007 Jun 9;369(9577):1947-54.

  16. Koestenbauer S, Zisch A, Dohr G, Zech NH. Protocols for hematopoietic stem cell expansion from umbilical cord blood. Cell Transplant. 2009;18(10):1059-68.

  17. Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation. Curr Opin Immunol. 2006 Oct;18(5):571-5.

  18. Stanevsky A, Shimoni A, Yerushalmi R, Nagler A. Cord blood stem cells for hematopoietic transplantation. Stem Cell Rev Rep. 2011 Jun;7(2):425-33. DOI: 10.1007/s12015-010-9183-9.

  19. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring microenvironment of hematopoietic tissuescloning in vitro and retransplantation in vivo. Transplantation. 1974 Apr;17(4):331-40.

  20. Resnick I, Stepensky P, Elkin G, Barkatz C, Gurevich O, Prigozhina T, et al. MSC for the improvement of hematopoietic engraftment Bone Marrow Transplant. 2010 Mar;45(3):605-6.

  21. Liaoa Y, Geyera MB, Yanga AJ, Cairoa MS. Cord blood transplantation and stem cell regenerative potential. Exp Hematol. 2011 Apr;39(4):393-412.

  22. Van Hennik PB, de Koning AE, Ploemacher RE. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood. 1999 Nov;94(9):3055-61.

  23. Castello S, Podesta M, Menditto VG, Ibatici A, Pitto A, Figari O, et al. Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol. 2004 Aug;32(8):782-7.

  24. Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, Kamiyama Y, et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells. 2004;22(2):125-34.

  25. Ramírez PA, Wagner JE, Brunstein CG. Going straight to the point: intra-BM injection of hematopoietic progenitors Bone Marrow Transplant. 2010 Jul;45(7):1127-33.

  26. Ikehara S. A novel BMT technique for treatment of various currently intractable diseases. Best Pract Res Clin Haematol. 2011 Sep;24(3):477-83.

  27. Hägglund H, Ringden O, Agren B, Wennberg L, Remberger M, Rundquist L, et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant. 1998 Feb;21(4):331-5.

  28. Frassoni F, Gualandi F, Podesta M, Raiola AM, Ibatici A, Piaggio G, et al. Direct intrabone transplant of unrelated cordblood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 2008 Sep;9(9):831-9.

  29. Brunstein CG, Barrer JN, Weisdorf DJ, Defor TE, McKenna D, Chong SY, et al. Intra-BM injection to enhace engrafment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant. 2009 Jun;43(12):935-40.

  30. Okada M, Yoshihara S, Taniguchi K, Kaida K, Ikegame K, Kato R, et al. Intra-bone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: A phase I study. Biol Blood Marrow Transplant. 2011 Aug 23. [Epub ahead of print] PMID:21867667.

  31. Klymenko SV, Belyi DA, Ross JR, Owzar K, Jiang C, Li Z, et al. Hematopoietic cell infusion for the treatment of nuclear disaster victims: New data from the Chernobyl accident. Int J Radiat Biol. 2011 Aug;87(8):846-50.




2020     |     www.medigraphic.com